Accordingly, this study aims to segment retinal layers in OCT images of patients with AMD or PCV who underwent anti-VEGF therapy to explore potential improvements in individual retinal layers and conduct a subregional assessment of the retina to study the treatment response of different regions against VEGF agents. This evidence concerns the gene VEGFA and age-related macular degeneration.